Optimise Finance Strategy. Deliver Accounting Precision. Maximise Business Outcomes.
Where Europe's life sciences finance and accounting leaders connect to master IFRS compliance, drive IPO readiness, modernise FP&A and lead with impact.
Discover What the Accounting & Reporting Europe Summit Has to Offer
Navigate Regulatory Complexity and Elevate Reporting Excellence
Master Evolving Regulatory and Technical Accounting Challenges: Address shifting US GAAP, IFRS and cross-border requirements while tackling high-judgment areas including IPR&D, intangibles, goodwill, grants, partnerships and segment reporting
Strengthen Governance, Controls and Audit Readiness: Build robust accounting infrastructure, internal controls and compliance processes that enable accurate, transparent and audit-ready reporting across the organisational lifecycle
Enhance Transparency Across Financial and Performance Reporting: Navigate non-GAAP measures, KPI consistency and cash flow classification while meeting increasing regulatory scrutiny and investor demands for comparability and clarity
Enable Capital Markets Readiness and Strategic Growth
Prepare for IPO and Global Capital Market Expectations: Align financial, operational and reporting capabilities with IPO readiness requirements, including IFRS implementation, cross-border reporting and evolving investor expectations
Optimise M&A, Valuation and R&D Collaboration Strategies: Benchmark deal structures, valuation frameworks and partnership models for pipelines, IP and R&D collaborations while managing accounting, reporting and investor implications
- Build Scalable and Modern Finance Operations: Leverage ERP systems, automation, shared services and treasury best practices to drive efficiency, scalability, liquidity management and long-term growth readiness
Drive Innovation, Manage Risk and Build Operational Resilience
Leverage AI and Digital Transformation in Finance: Deploy practical AI use cases across FP&A, forecasting, scenario planning and reporting to enhance speed, accuracy and decision-making insight
Strengthen Risk Management and Organisational Resilience: Identify early warning signals, address governance breakdowns and implement stronger controls informed by real-world financial and operational setbacks
- Navigate Macroeconomic Volatility and Operational Pressures: Manage the financial impact of geopolitical shifts, supply chain disruption and market uncertainty on reporting, liquidity and strategic decision-making
Who is this event designed for?
This summit is designed for pharmaceutical, biotech and medical device leaders who recognise that staying ahead of industry disruption is non-negotiable. Life Sciences professionals hold responsibility in:
Accounting
Auditing
Finance
Reporting
Revenue
Forecasting
Transactions
Risk and Controls
Contracts
Financial Planning
Business Decision Support
Business/Corporate Development
Engage a qualified audience of senior finance and accounting leaders!
Whether you're looking to generate quality leads, showcase thought leadership expertise, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
To learn more about sponsorship opportunities, contact:
Matt Hannon (Companies #, A-K): MattH@informaconnectls.com
Lisa Marzoli (Companies L-Z): LisaM@informaconnectls.com
FAQs
What is the Life Sciences Accounting & Reporting Europe Summit?
The Life Sciences Accounting & Reporting Europe Summit is the premier European forum where top pharma and biotech finance leaders gather to address industry-specific accounting challenges and transform them into competitive advantages. This is the inaugural European event, launched following the success of our US event Life Sciences Accounting & Reporting Congress.
When and where is the Life Sciences Accounting & Reporting Europe Summit taking place?
Life Sciences Accounting & Reporting Europe takes place on 17-18 November 2026 at The View, Royal College of Surgeons, London, UK.
Who should attend?
This conference is designed for senior finance and accounting professionals working in the pharmaceutical, biotechnology and life sciences sectors.
Ideal attendees include:
- Chief Financial Officers (CFOs) and Vice Presidents of Finance
- Controllers and Assistant Controllers
- Financial Planning & Analysis (FP&A) Directors and Managers
- Accounting Managers and Financial Reporting Managers
- Corporate Development and Treasury leaders
- Professionals from emerging biotech startups, mid-sized pharmaceutical companies, and established life sciences organizations
- Anyone seeking targeted insights on pharma cost accounting, IFRS compliance, and revenue recognition
What topics are covered within accounting and reporting at the congress?
The conference agenda addresses the most critical financial and accounting challenges facing the life sciences industry today.
Core topics include:
- Financial statement presentation and investor relations
- Regulatory compliance and auditing standards
- Revenue recognition and contract accounting
- Pharmaceutical cost accounting methodologies
- Forecasting methodologies and risk controls
- Supply chain financial management
- Shared services implementation and technology automation
- M&A and licensing strategy
- R&D investment analysis and portfolio optimization
- Next-generation financial technologies and digital transformation
- Strategic financial stewardship for sustainable value creation
Will there be opportunities for networking?
Networking is a cornerstone of the conference experience, offering multiple opportunities to connect with Europe's top pharma and biotech finance community.
Networking features include:
- One-on-one meeting scheduling with peers and expert speakers
- Dedicated networking sessions and executive roundtables
- Interactive discussion forums on key industry challenges
- Informal gathering opportunities throughout the event
- Ability to benchmark strategies with fellow CFOs and finance leaders
- Long-term professional relationship building with decision-makers across Europe
- Exchange of best practices and solutions to common financial challenges